Isnani, Ayang .
HRN: 26-05-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2024
MUPIROCIN 2%, 15G (TUBE)
10/15/2024
10/20/2024
TOPICAL
2%
BID
S/P LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes